Carlsmed, Inc. (CARL)
Carlsmed will go public soon. The estimated IPO date is July 23, 2025.
IPO Price Range
$14.00 - $16.00
Shares Offered
6,700,000
Deal Size
$100.50M
Carlsmed Revenue
Carlsmed had revenue of $32.27M in the twelve months ending March 31, 2025. In the year 2024, Carlsmed had annual revenue of $27.17M with 97.16% growth.
Revenue (ttm)
$32.27M
Revenue Growth
+97.16%
P/S Ratio
12.33
Revenue / Employee
$322,680
Employees
100
Market Cap
397.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 1 day ago - U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings - Seeking Alpha
- 5 days ago - Carlsmed Announces Launch of Initial Public Offering - Business Wire
- 19 days ago - Carlsmed Files For IPO On High Growth And High Operating Losses - Seeking Alpha
- 23 days ago - Spine surgery-focused medtech Carlsmed files for a $100 million IPO - Renaissance Capital
- 23 days ago - Carlsmed Announces Filing of Registration Statement for Proposed Initial Public Offering - BUSINESS WIRE
- 23 days ago - Carlsmed IPO Registration Document (S-1) - SEC